Skip to content
OpenCapital
Get started

Xtant Medical Holdings XTNT Debt Maturity - 2025

Debt Maturity - 2025 at other companies

Bioventus logo
BioventusBVS
——

Other financials

Income statement

See full
Revenue$20.9M-36.5%
Gross profit$12.0M-40.9%
Operating income-$2.9M-375%
Net income-$3.1M-5,426%
EPS (diluted)-$0.02—

Balance sheet

See full
Cash & equivalents$12.2M+124%
Total debt$15.0M-34.9%
Total equity$48.6M+10.8%
Total assets$78.0M-18.6%

Cash flow

See full
Operating cash flow-$2.1M-265%
CapEx$194.0K-83.7%
Free cash flow-$2.3M-2,753%

Valuation

See full
Market cap$59.05M-32.5%
Enterprise value$61.89M-41.5%
P/E32.3×—
P/S0.5×-0.2×

Profitability

See full
Gross margin62.3%+4.2pp
Operating margin4.8%+2.8pp
Net margin1.5%+0.8pp
FCF margin6.4%+4.1pp

Returns & leverage

See full
Return on equity3.9%+2.1pp
Debt / equity0.3×-0.2×
Current ratio3.3×+1.0×

Where this comes from

Reported directly by Xtant Medical Holdings in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo.

The official record: Xtant Medical Holdings’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xtant Medical Holdings's debt maturity - 2025.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xtant Medical Holdings's debt maturity - 2025?
Xtant Medical Holdings (XTNT) reported debt maturity - 2025 of $52K in Q4 2025.
What is the long-term trend for Xtant Medical Holdings's debt maturity - 2025?
Over 2 years (2023 to 2025), Xtant Medical Holdings's debt maturity - 2025 has grown at a -82.6% compound annual growth rate (CAGR), from $1.73M to $52K.
What does debt maturity - 2025 mean?
This metric quantifies the total principal amount of long-term debt obligations scheduled to mature during the 2025 fiscal year. It is a critical indicator for assessing near-term liquidity risk and the company's ability to refinance or repay debt without disrupting operations. Investors use this to evaluate the company's capital structure stability and potential future cash flow requirements.